nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Liver fatty—Octreotide—thymus cancer	0.05	0.0695	CcSEcCtD
Capecitabine—Hepatic steatosis—Octreotide—thymus cancer	0.0208	0.0288	CcSEcCtD
Capecitabine—CDA—hematopoietic system—thymus cancer	0.0193	0.0689	CbGeAlD
Capecitabine—Varicose vein—Octreotide—thymus cancer	0.0168	0.0234	CcSEcCtD
Capecitabine—Hepatitis cholestatic—Octreotide—thymus cancer	0.0156	0.0216	CcSEcCtD
Capecitabine—VIIth nerve paralysis—Octreotide—thymus cancer	0.0153	0.0212	CcSEcCtD
Capecitabine—DPYD—cardiac atrium—thymus cancer	0.0152	0.0544	CbGeAlD
Capecitabine—CDA—lymphoid tissue—thymus cancer	0.0136	0.0485	CbGeAlD
Capecitabine—CES1—neck—thymus cancer	0.0135	0.0481	CbGeAlD
Capecitabine—Proctalgia—Octreotide—thymus cancer	0.0134	0.0186	CcSEcCtD
Capecitabine—DPYD—bone marrow—thymus cancer	0.0128	0.0459	CbGeAlD
Capecitabine—DPYD—thyroid gland—thymus cancer	0.0128	0.0458	CbGeAlD
Capecitabine—Rectal disorder—Octreotide—thymus cancer	0.0128	0.0178	CcSEcCtD
Capecitabine—CDA—bone marrow—thymus cancer	0.0124	0.0442	CbGeAlD
Capecitabine—CDA—thyroid gland—thymus cancer	0.0123	0.0441	CbGeAlD
Capecitabine—Anorectal disorder—Octreotide—thymus cancer	0.0119	0.0166	CcSEcCtD
Capecitabine—DPYD—lung—thymus cancer	0.0116	0.0416	CbGeAlD
Capecitabine—TYMP—hematopoietic system—thymus cancer	0.0116	0.0415	CbGeAlD
Capecitabine—Haemorrhoids—Octreotide—thymus cancer	0.0107	0.0148	CcSEcCtD
Capecitabine—CES1—hematopoietic system—thymus cancer	0.01	0.0358	CbGeAlD
Capecitabine—Haematoma—Octreotide—thymus cancer	0.00998	0.0139	CcSEcCtD
Capecitabine—TYMS—hematopoietic system—thymus cancer	0.00996	0.0356	CbGeAlD
Capecitabine—Hypothyroidism—Octreotide—thymus cancer	0.00978	0.0136	CcSEcCtD
Capecitabine—Nail disorder—Octreotide—thymus cancer	0.00968	0.0134	CcSEcCtD
Capecitabine—Intestinal obstruction—Octreotide—thymus cancer	0.00921	0.0128	CcSEcCtD
Capecitabine—Neuralgia—Octreotide—thymus cancer	0.00903	0.0125	CcSEcCtD
Capecitabine—TYMP—cardiac atrium—thymus cancer	0.00882	0.0315	CbGeAlD
Capecitabine—Metrorrhagia—Octreotide—thymus cancer	0.00879	0.0122	CcSEcCtD
Capecitabine—Throat sore—Octreotide—thymus cancer	0.00871	0.0121	CcSEcCtD
Capecitabine—Oropharyngeal discomfort—Octreotide—thymus cancer	0.00863	0.012	CcSEcCtD
Capecitabine—TYMP—pituitary gland—thymus cancer	0.00861	0.0308	CbGeAlD
Capecitabine—Herpes zoster—Octreotide—thymus cancer	0.00833	0.0116	CcSEcCtD
Capecitabine—TYMP—lymphoid tissue—thymus cancer	0.00817	0.0292	CbGeAlD
Capecitabine—Otitis media—Octreotide—thymus cancer	0.00806	0.0112	CcSEcCtD
Capecitabine—Coagulopathy—Octreotide—thymus cancer	0.00806	0.0112	CcSEcCtD
Capecitabine—DPYD—lymph node—thymus cancer	0.00796	0.0285	CbGeAlD
Capecitabine—Tingling sensation—Octreotide—thymus cancer	0.00781	0.0108	CcSEcCtD
Capecitabine—Injection site pain—Octreotide—thymus cancer	0.00769	0.0107	CcSEcCtD
Capecitabine—CDA—lymph node—thymus cancer	0.00766	0.0274	CbGeAlD
Capecitabine—Petechiae—Octreotide—thymus cancer	0.00763	0.0106	CcSEcCtD
Capecitabine—TYMP—bone marrow—thymus cancer	0.00744	0.0266	CbGeAlD
Capecitabine—TYMP—thyroid gland—thymus cancer	0.00742	0.0265	CbGeAlD
Capecitabine—Contusion—Octreotide—thymus cancer	0.00719	0.00999	CcSEcCtD
Capecitabine—CES1—lymphoid tissue—thymus cancer	0.00706	0.0252	CbGeAlD
Capecitabine—TYMS—lymphoid tissue—thymus cancer	0.00701	0.0251	CbGeAlD
Capecitabine—Rectal haemorrhage—Octreotide—thymus cancer	0.00695	0.00965	CcSEcCtD
Capecitabine—Oropharyngeal pain—Octreotide—thymus cancer	0.0069	0.00958	CcSEcCtD
Capecitabine—Cellulitis—Octreotide—thymus cancer	0.0069	0.00958	CcSEcCtD
Capecitabine—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0069	0.00958	CcSEcCtD
Capecitabine—Herpes simplex—Octreotide—thymus cancer	0.00681	0.00945	CcSEcCtD
Capecitabine—TYMP—lung—thymus cancer	0.00674	0.0241	CbGeAlD
Capecitabine—Hearing impaired—Octreotide—thymus cancer	0.00659	0.00915	CcSEcCtD
Capecitabine—CES1—thyroid gland—thymus cancer	0.00641	0.0229	CbGeAlD
Capecitabine—TYMS—bone marrow—thymus cancer	0.00639	0.0228	CbGeAlD
Capecitabine—TYMS—thyroid gland—thymus cancer	0.00637	0.0228	CbGeAlD
Capecitabine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00628	0.00871	CcSEcCtD
Capecitabine—Injection site reaction—Octreotide—thymus cancer	0.00624	0.00866	CcSEcCtD
Capecitabine—Influenza like illness—Octreotide—thymus cancer	0.00609	0.00846	CcSEcCtD
Capecitabine—Candida infection—Octreotide—thymus cancer	0.00599	0.00832	CcSEcCtD
Capecitabine—Neuropathy—Octreotide—thymus cancer	0.00589	0.00818	CcSEcCtD
Capecitabine—CES1—lung—thymus cancer	0.00582	0.0208	CbGeAlD
Capecitabine—TYMS—lung—thymus cancer	0.00579	0.0207	CbGeAlD
Capecitabine—Urine output increased—Octreotide—thymus cancer	0.00567	0.00788	CcSEcCtD
Capecitabine—Mouth ulceration—Octreotide—thymus cancer	0.00567	0.00788	CcSEcCtD
Capecitabine—Phlebitis—Octreotide—thymus cancer	0.00529	0.00734	CcSEcCtD
Capecitabine—Sleep disorder—Octreotide—thymus cancer	0.00526	0.00731	CcSEcCtD
Capecitabine—Thrombophlebitis—Octreotide—thymus cancer	0.00526	0.00731	CcSEcCtD
Capecitabine—Diabetes mellitus—Octreotide—thymus cancer	0.00524	0.00727	CcSEcCtD
Capecitabine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00524	0.00727	CcSEcCtD
Capecitabine—Polyuria—Octreotide—thymus cancer	0.00519	0.0072	CcSEcCtD
Capecitabine—Gastroenteritis—Octreotide—thymus cancer	0.00514	0.00714	CcSEcCtD
Capecitabine—Deafness—Octreotide—thymus cancer	0.00509	0.00707	CcSEcCtD
Capecitabine—Hot flush—Octreotide—thymus cancer	0.00487	0.00676	CcSEcCtD
Capecitabine—Amnesia—Octreotide—thymus cancer	0.00485	0.00673	CcSEcCtD
Capecitabine—Menopausal symptoms—Octreotide—thymus cancer	0.00483	0.0067	CcSEcCtD
Capecitabine—Arthritis—Octreotide—thymus cancer	0.00469	0.00651	CcSEcCtD
Capecitabine—TYMP—lymph node—thymus cancer	0.00461	0.0165	CbGeAlD
Capecitabine—Osteoarthritis—Octreotide—thymus cancer	0.00456	0.00632	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00456	0.00632	CcSEcCtD
Capecitabine—Pain in extremity—Octreotide—thymus cancer	0.00456	0.00632	CcSEcCtD
Capecitabine—CYP2C9—hematopoietic system—thymus cancer	0.00435	0.0156	CbGeAlD
Capecitabine—Irritability—Octreotide—thymus cancer	0.00435	0.00604	CcSEcCtD
Capecitabine—Dehydration—Octreotide—thymus cancer	0.00424	0.00588	CcSEcCtD
Capecitabine—Dry skin—Octreotide—thymus cancer	0.00418	0.0058	CcSEcCtD
Capecitabine—Abdominal pain upper—Octreotide—thymus cancer	0.00416	0.00578	CcSEcCtD
Capecitabine—Nasopharyngitis—Octreotide—thymus cancer	0.00407	0.00566	CcSEcCtD
Capecitabine—Gastritis—Octreotide—thymus cancer	0.00403	0.0056	CcSEcCtD
Capecitabine—Muscular weakness—Octreotide—thymus cancer	0.00402	0.00558	CcSEcCtD
Capecitabine—CES1—lymph node—thymus cancer	0.00398	0.0142	CbGeAlD
Capecitabine—Abdominal distension—Octreotide—thymus cancer	0.00396	0.0055	CcSEcCtD
Capecitabine—TYMS—lymph node—thymus cancer	0.00396	0.0141	CbGeAlD
Capecitabine—Asthma—Octreotide—thymus cancer	0.00394	0.00547	CcSEcCtD
Capecitabine—Influenza—Octreotide—thymus cancer	0.00394	0.00547	CcSEcCtD
Capecitabine—Bronchospasm—Octreotide—thymus cancer	0.00387	0.00538	CcSEcCtD
Capecitabine—Sweating increased—Octreotide—thymus cancer	0.00384	0.00532	CcSEcCtD
Capecitabine—Bronchitis—Octreotide—thymus cancer	0.00379	0.00526	CcSEcCtD
Capecitabine—Abdominal discomfort—Octreotide—thymus cancer	0.00377	0.00524	CcSEcCtD
Capecitabine—Dysuria—Octreotide—thymus cancer	0.00368	0.00511	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Octreotide—thymus cancer	0.00366	0.00508	CcSEcCtD
Capecitabine—Weight increased—Octreotide—thymus cancer	0.00358	0.00497	CcSEcCtD
Capecitabine—Weight decreased—Octreotide—thymus cancer	0.00356	0.00495	CcSEcCtD
Capecitabine—Hyperglycaemia—Octreotide—thymus cancer	0.00355	0.00493	CcSEcCtD
Capecitabine—Pneumonia—Octreotide—thymus cancer	0.00353	0.0049	CcSEcCtD
Capecitabine—Depression—Octreotide—thymus cancer	0.0035	0.00486	CcSEcCtD
Capecitabine—Neuropathy peripheral—Octreotide—thymus cancer	0.00344	0.00478	CcSEcCtD
Capecitabine—Jaundice—Octreotide—thymus cancer	0.00342	0.00475	CcSEcCtD
Capecitabine—Conjunctivitis—Octreotide—thymus cancer	0.00341	0.00474	CcSEcCtD
Capecitabine—Urinary tract infection—Octreotide—thymus cancer	0.00341	0.00474	CcSEcCtD
Capecitabine—Haematuria—Octreotide—thymus cancer	0.00335	0.00465	CcSEcCtD
Capecitabine—Hepatobiliary disease—Octreotide—thymus cancer	0.00332	0.00461	CcSEcCtD
Capecitabine—Epistaxis—Octreotide—thymus cancer	0.00331	0.0046	CcSEcCtD
Capecitabine—Bradycardia—Octreotide—thymus cancer	0.00321	0.00445	CcSEcCtD
Capecitabine—Rhinitis—Octreotide—thymus cancer	0.00316	0.00439	CcSEcCtD
Capecitabine—Hepatitis—Octreotide—thymus cancer	0.00315	0.00438	CcSEcCtD
Capecitabine—Hypoaesthesia—Octreotide—thymus cancer	0.00314	0.00435	CcSEcCtD
Capecitabine—Pharyngitis—Octreotide—thymus cancer	0.00313	0.00434	CcSEcCtD
Capecitabine—Oedema peripheral—Octreotide—thymus cancer	0.0031	0.00431	CcSEcCtD
Capecitabine—Visual impairment—Octreotide—thymus cancer	0.00304	0.00422	CcSEcCtD
Capecitabine—Tinnitus—Octreotide—thymus cancer	0.00294	0.00408	CcSEcCtD
Capecitabine—Flushing—Octreotide—thymus cancer	0.00292	0.00406	CcSEcCtD
Capecitabine—Cardiac disorder—Octreotide—thymus cancer	0.00292	0.00406	CcSEcCtD
Capecitabine—Immune system disorder—Octreotide—thymus cancer	0.00285	0.00395	CcSEcCtD
Capecitabine—Arrhythmia—Octreotide—thymus cancer	0.00282	0.00391	CcSEcCtD
Capecitabine—Alopecia—Octreotide—thymus cancer	0.00278	0.00387	CcSEcCtD
Capecitabine—Mental disorder—Octreotide—thymus cancer	0.00276	0.00383	CcSEcCtD
Capecitabine—Erythema—Octreotide—thymus cancer	0.00274	0.00381	CcSEcCtD
Capecitabine—Malnutrition—Octreotide—thymus cancer	0.00274	0.00381	CcSEcCtD
Capecitabine—Flatulence—Octreotide—thymus cancer	0.0027	0.00375	CcSEcCtD
Capecitabine—Back pain—Octreotide—thymus cancer	0.00265	0.00368	CcSEcCtD
Capecitabine—Muscle spasms—Octreotide—thymus cancer	0.00264	0.00366	CcSEcCtD
Capecitabine—Vision blurred—Octreotide—thymus cancer	0.00259	0.00359	CcSEcCtD
Capecitabine—Tremor—Octreotide—thymus cancer	0.00257	0.00357	CcSEcCtD
Capecitabine—Ill-defined disorder—Octreotide—thymus cancer	0.00255	0.00353	CcSEcCtD
Capecitabine—Anaemia—Octreotide—thymus cancer	0.00254	0.00352	CcSEcCtD
Capecitabine—Malaise—Octreotide—thymus cancer	0.00247	0.00343	CcSEcCtD
Capecitabine—Vertigo—Octreotide—thymus cancer	0.00246	0.00342	CcSEcCtD
Capecitabine—Syncope—Octreotide—thymus cancer	0.00246	0.00342	CcSEcCtD
Capecitabine—Palpitations—Octreotide—thymus cancer	0.00242	0.00337	CcSEcCtD
Capecitabine—Loss of consciousness—Octreotide—thymus cancer	0.00241	0.00335	CcSEcCtD
Capecitabine—Cough—Octreotide—thymus cancer	0.00239	0.00332	CcSEcCtD
Capecitabine—Hypertension—Octreotide—thymus cancer	0.00237	0.00329	CcSEcCtD
Capecitabine—Chest pain—Octreotide—thymus cancer	0.00234	0.00324	CcSEcCtD
Capecitabine—Myalgia—Octreotide—thymus cancer	0.00234	0.00324	CcSEcCtD
Capecitabine—Arthralgia—Octreotide—thymus cancer	0.00234	0.00324	CcSEcCtD
Capecitabine—Anxiety—Octreotide—thymus cancer	0.00233	0.00323	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00232	0.00322	CcSEcCtD
Capecitabine—Discomfort—Octreotide—thymus cancer	0.00231	0.0032	CcSEcCtD
Capecitabine—Dry mouth—Octreotide—thymus cancer	0.00228	0.00317	CcSEcCtD
Capecitabine—Oedema—Octreotide—thymus cancer	0.00224	0.00311	CcSEcCtD
Capecitabine—Infection—Octreotide—thymus cancer	0.00222	0.00309	CcSEcCtD
Capecitabine—Shock—Octreotide—thymus cancer	0.0022	0.00306	CcSEcCtD
Capecitabine—Nervous system disorder—Octreotide—thymus cancer	0.0022	0.00305	CcSEcCtD
Capecitabine—Thrombocytopenia—Octreotide—thymus cancer	0.00219	0.00304	CcSEcCtD
Capecitabine—Tachycardia—Octreotide—thymus cancer	0.00219	0.00303	CcSEcCtD
Capecitabine—Skin disorder—Octreotide—thymus cancer	0.00217	0.00302	CcSEcCtD
Capecitabine—Hyperhidrosis—Octreotide—thymus cancer	0.00216	0.003	CcSEcCtD
Capecitabine—Anorexia—Octreotide—thymus cancer	0.00213	0.00296	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00204	0.00283	CcSEcCtD
Capecitabine—Insomnia—Octreotide—thymus cancer	0.00203	0.00281	CcSEcCtD
Capecitabine—Paraesthesia—Octreotide—thymus cancer	0.00201	0.00279	CcSEcCtD
Capecitabine—Dyspnoea—Octreotide—thymus cancer	0.002	0.00277	CcSEcCtD
Capecitabine—Dyspepsia—Octreotide—thymus cancer	0.00197	0.00274	CcSEcCtD
Capecitabine—Decreased appetite—Octreotide—thymus cancer	0.00195	0.0027	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00193	0.00268	CcSEcCtD
Capecitabine—Fatigue—Octreotide—thymus cancer	0.00193	0.00268	CcSEcCtD
Capecitabine—Pain—Octreotide—thymus cancer	0.00191	0.00266	CcSEcCtD
Capecitabine—Constipation—Octreotide—thymus cancer	0.00191	0.00266	CcSEcCtD
Capecitabine—Feeling abnormal—Octreotide—thymus cancer	0.00185	0.00256	CcSEcCtD
Capecitabine—Gastrointestinal pain—Octreotide—thymus cancer	0.00183	0.00254	CcSEcCtD
Capecitabine—Urticaria—Octreotide—thymus cancer	0.00178	0.00247	CcSEcCtD
Capecitabine—Body temperature increased—Octreotide—thymus cancer	0.00177	0.00246	CcSEcCtD
Capecitabine—Abdominal pain—Octreotide—thymus cancer	0.00177	0.00246	CcSEcCtD
Capecitabine—Hypersensitivity—Octreotide—thymus cancer	0.00165	0.00229	CcSEcCtD
Capecitabine—Asthenia—Octreotide—thymus cancer	0.00161	0.00223	CcSEcCtD
Capecitabine—Pruritus—Octreotide—thymus cancer	0.00158	0.0022	CcSEcCtD
Capecitabine—Diarrhoea—Octreotide—thymus cancer	0.00153	0.00213	CcSEcCtD
Capecitabine—Dizziness—Octreotide—thymus cancer	0.00148	0.00206	CcSEcCtD
Capecitabine—Vomiting—Octreotide—thymus cancer	0.00142	0.00198	CcSEcCtD
Capecitabine—Rash—Octreotide—thymus cancer	0.00141	0.00196	CcSEcCtD
Capecitabine—Dermatitis—Octreotide—thymus cancer	0.00141	0.00196	CcSEcCtD
Capecitabine—Headache—Octreotide—thymus cancer	0.0014	0.00195	CcSEcCtD
Capecitabine—Nausea—Octreotide—thymus cancer	0.00133	0.00185	CcSEcCtD
